MEDIF
ActiveSummary
MEDIF has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €434,460 and a net result of -€55,010. Equity remains stable across the filed fiscal years (±1.5% per year). Its solvency ranks better than 53% of 526 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability8▼-4
Solvency90▼-7
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24,000 at 30 days acceptable
Liquidity short (current ratio 0.19 against 0.4 in 2024; short-term debt: 35% and cash: 5.6% of total assets), and 35% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€55,010
neutral · Filed after the deadline
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 28-05-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
28 d late
2024
16 d late
2023
29 d late
2022
3 d late
2021
23 d late
2020
28 d late
2019
20 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 21 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 23 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today30-09-2026 close30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€434,460▼ 11.2%
2024 · €489,470
Total assets
€668,161▼ 2.0%
2024 · €681,615
Net result
-€55,010▼ 58.0%
2024 · -€34,814
Working capital
-€188,582▼ 62.3%
2024 · -€116,222
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€109,023€58,262▼ 46.6%€93▼ 99.8%-€34,574-€54,768▼ 58.4%
Net result€81,913within the sector's middle half€38,870within the sector's middle half▼ 52.5%-€5,963below the sector's middle half-€34,814below the sector's middle half▼ 484%-€55,010below the sector's middle half▼ 58.0%
Equity€491,376above the sector's middle half▲ 20.0%€530,246above the sector's middle half▲ 7.9%€524,284above the sector's middle half▼ 1.1%€489,470above the sector's middle half▼ 6.6%€434,460above the sector's middle half▼ 11.2%
Total assets€658,825within the sector's middle half▲ 27.5%€655,264within the sector's middle half▼ 0.5%€664,520above the sector's middle half▲ 1.4%€681,615above the sector's middle half▲ 2.6%€668,161above the sector's middle half▼ 2.0%
Debt€167,448▲ 56.1%€125,017▼ 25.3%€140,237▲ 12.2%€192,146▲ 37.0%€233,701▲ 21.6%
Working capital€10,383below the sector's middle half€27,774within the sector's middle half▲ 167%-€67,739below the sector's middle half-€116,222below the sector's middle half▼ 71.6%-€188,582below the sector's middle half▼ 62.3%
Solvency74.6%within the sector's middle half▼ 4.7pp80.9%within the sector's middle half▲ 6.3pp78.9%within the sector's middle half▼ 2.0pp71.8%within the sector's middle half▼ 7.1pp65.0%within the sector's middle half▼ 6.8pp
Current ratio1.06below the sector's middle half▲ 0.551.22below the sector's middle half▲ 0.160.52below the sector's middle half▼ 0.710.40below the sector's middle half▼ 0.120.19below the sector's middle half▼ 0.20
Return on assets (ROA)12.4%within the sector's middle half▲ 15.4pp5.9%within the sector's middle half▼ 6.5pp-0.9%below the sector's middle half▼ 6.8pp-5.1%below the sector's middle half▼ 4.2pp-8.2%below the sector's middle half▼ 3.1pp
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €54,768 in 2025 against €34,574 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €668,161
Fixed assets
€623,042 ▲ 2.9%
Current assets
€45,119 ▼ 40.6%
Equity and liabilities €668,161
Equity
€434,460 ▼ 11.2%
Debt
€233,701 ▲ 21.6%
Debt's share of the balance-sheet total rises from 28.2% to 35.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
-€46,665▼
2024 · -€27,149
Cash flow
-€46,906▼
2024 · -€27,389
Debt to equity
0.54▲
2024 · 0.39
ROE
-12.7%▼
2024 · -7.1%
Interest coverage
-175.50▼
2024 · -106.31
Debt ≤ 1 year
€233,701▲
2024 · €192,146
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €1,620 | - | €96 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €7,396 | €12,768 | €13,576 | €7,425 | €8,104 | ▲ 9.1% |
| Other operating charges640/8 | €216 | €288 | €127 | €350 | €370 | ▲ 5.7% |
| Gross operating margin9900 | €118,256 | €71,317 | €13,893 | -€26,799 | -€46,295 | ▼ 72.7% |
| Operating profit (loss)9901 | €109,023 | €58,262 | €93 | -€34,574 | -€54,768 | ▼ 58.4% |
| Financial income75/76B | - | €0 | €5 | €16 | €24 | ▲ 55.9% |
| Recurring financial income75 | - | €0 | €5 | €16 | €24 | ▲ 55.9% |
| Financial charges65/66B | €3,854 | €4,076 | €4,697 | €255 | €266 | ▲ 4.1% |
| Recurring financial charges65 | €3,679 | €4,076 | €4,614 | €255 | €266 | ▲ 4.1% |
| Non-recurring financial charges66B | €175 | - | €83 | - | - | - |
| Profit (loss) for the period before taxes9903 | €105,169 | €54,186 | -€4,599 | -€34,814 | -€55,010 | ▼ 58.0% |
| Income taxes67/77 | €23,256 | €15,316 | €1,364 | -€0 | - | - |
| Profit (loss) for the period9904 | €81,913 | €38,870 | -€5,963 | -€34,814 | -€55,010 | ▼ 58.0% |
| Profit (loss) for the period to be appropriated9905 | €81,913 | €38,870 | -€5,963 | -€34,814 | -€55,010 | ▼ 58.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €658,825 | €655,264 | €664,520 | €681,615 | €668,161 | ▼ 2.0% |
| Fixed assets21/28 | €480,993 | €502,472 | €592,023 | €605,692 | €623,042 | ▲ 2.9% |
| Tangible fixed assets22/27 | €210,881 | €209,743 | €207,328 | €205,817 | €209,402 | ▲ 1.7% |
| Land and buildings22 | €185,224 | €183,153 | €178,239 | €173,326 | €168,413 | ▼ 2.8% |
| Plant, machinery and equipment23 | €1,192 | €932 | €1,748 | €6,082 | €5,728 | ▼ 5.8% |
| Furniture and vehicles24 | €24,465 | €25,659 | €27,341 | €26,408 | €35,261 | ▲ 33.5% |
| Financial fixed assets28 | €270,112 | €292,729 | €384,695 | €399,876 | €413,640 | ▲ 3.4% |
| Current assets29/58 | €177,832 | €152,791 | €72,497 | €75,923 | €45,119 | ▼ 40.6% |
| Amounts receivable within one year40/41 | €137,792 | €16,126 | €2,714 | €71,540 | €7,468 | ▼ 89.6% |
| Trade receivables40 | €136,655 | - | - | €40,322 | €6,229 | ▼ 84.6% |
| Other amounts receivable41 | €1,137 | €16,126 | €2,714 | €31,218 | €1,239 | ▼ 96.0% |
| Cash at bank and in hand54/58 | €39,796 | €136,337 | €69,455 | €4,054 | €37,570 | ▲ 827% |
| Deferred charges and accrued income490/1 | €243 | €329 | €329 | €329 | €81 | ▼ 75.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €658,825 | €655,264 | €664,520 | €681,615 | €668,161 | ▼ 2.0% |
| Equity10/15 | €491,376 | €530,246 | €524,284 | €489,470 | €434,460 | ▼ 11.2% |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €485,176 | €524,046 | €518,084 | €483,270 | €428,260 | ▼ 11.4% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | €483,316 | €522,186 | €516,224 | €481,410 | €426,400 | ▼ 11.4% |
| Amounts payable17/49 | €167,448 | €125,017 | €140,237 | €192,146 | €233,701 | ▲ 21.6% |
| Amounts payable within one year42/48 | €167,448 | €125,017 | €140,237 | €192,146 | €233,701 | ▲ 21.6% |
| Trade debts44 | €10,650 | €10,518 | €12,681 | €22,165 | €28,499 | ▲ 28.6% |
| Suppliers440/4 | - | - | - | €22,165 | €28,499 | ▲ 28.6% |
| Bills of exchange payable441 | €10,650 | €10,518 | €12,681 | - | - | - |
| Taxes, remuneration and social security45 | €42,936 | €3,548 | €1,364 | €4,290 | €129 | ▼ 97.0% |
| Taxes450/3 | €42,936 | €3,548 | €1,364 | €4,290 | €129 | ▼ 97.0% |
| Other amounts payable47/48 | €113,862 | €110,951 | €126,193 | €165,691 | €205,073 | ▲ 23.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €81,913 | €38,870 | -€5,963 | -€34,814 | -€55,010 | ▼ 58.0% |
| + Depreciation and write-downs630 | €7,396 | €12,768 | €13,576 | €7,425 | €8,104 | ▲ 9.1% |
| Operating cash flow (approximation) | €89,309 | €51,638 | €7,614 | -€27,389 | -€46,906 | ▼ 71.3% |
| Investment in fixed assets (approximation) | - | -€34,247 | -€103,127 | -€21,094 | -€25,453 | ▼ 20.7% |
| Change in cash | - | €96,540 | -€66,882 | -€65,401 | €33,516 | ▲ 151% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
30-09
Financial
Weakest financial yearnet -€55,010
Net result drops to -€55,010, the lowest in the series.
16-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 16 days late
2024
29-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
03-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 3 days late
2022
30-09
Financial
Equity above €500,000Eq €530,246 ▲7.9%
2 profitable years in a row build equity to €530,246.
23-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 23 days late
2021
30-09
Financial
Back to profitnet €81,913
Net result €81,913 after 3 loss-making years.
30-09
Financial
Liquidity doublescurrent ratio 1.06
Current ratio from 0.51 to 1.06.
28-05
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 28 days late
2020
20-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 20 days late
2019
29-05
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
05-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 66 days late
2017
30-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Thuin · 1 establishment unit since 2011
Ground area
182 m²
Building footprint
122 m²
Parcel 56030B0180/00V003, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rue de Marchienne(GOZ) 113, 6534 Thuin
since 20112.195.225.113
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 56030B0180/00V003 | Wallonia | 182 m² | 1 · 122 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 30-09-2025 list no shareholders, and no other source names one.
Holdings 1
- LA MAISON DE CHAMBOULIVEFRsubsidiarySourceown accounts 30-09-202593.75%
According to the annual accounts to 30-09-2025 of MEDIF and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
CLOUDMEN
BE 0878.688.455
Antwerpen · Eq €430,656
Médical Dr MASSET
BE 0808.667.818
Blégny · Eq €439,141
ENDUROMED
BE 0888.032.030
Deinze · Eq €429,606
HERA
BE 0441.391.273
Mechelen · Eq €439,531
Airlines International Representation in Europe
BE 0424.052.821
Etterbeek · Eq €441,417
Of 1,177 companies in sector 72109 we hold annual accounts for 717. 494 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded29-12-2006
Fiscal year end30-09
Activities, NACEBEL 2025
72109Other research and development on natural sciences
85592Vocational training
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID
0208:0886004928
Registered
08-01-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.